Â鶹´«Ã½

Skip to main content

FTC Bureau of Economics Working Papers are preliminary materials circulated to stimulate discussion and critical comment. The analyses and conclusions set forth are those of the authors and do not necessarily reflect the views of other members of the Bureau of Economics, other Commission staff, or the Commission itself. References in publications to FTC Bureau of Economics Working Papers by FTC economists (other than acknowledgment by a writer that he has access to such unpublished materials) should be cleared with the author to protect the tentative character of these papers.

Working Papers are in PDF format. If you have trouble accessing one of these papers, please email ReportRequests@ftc.gov.

Generic Drug Industry Dynamics

Authors
David Reiffen and Michael R. Ward
Working Paper
248

Because of its unique institutional and regulatory features, the generic drug industry provides a useful laboratory for understanding how competition evolves within a market. We exploit these features